| 000 | 01794 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514060626.0 | ||
| 264 | 0 | _c20030827 | |
| 008 | 200308s 0 0 spa d | ||
| 022 | _a0300-2896 | ||
| 024 | 7 |
_a10.1016/s0300-2896(03)75327-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJaén Olasolo, J | |
| 245 | 0 | 0 |
_a[Non-small cell lung cancer. Survival after radiotherapy and prognostic factors]. _h[electronic resource] |
| 260 |
_bArchivos de bronconeumologia _cFeb 2003 |
||
| 300 |
_a81-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 |
_aEsophagus _xradiation effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLarynx _xradiation effects |
| 650 | 0 | 4 | _aLife Tables |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aLymphatic Irradiation |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aRadiation Injuries _xepidemiology |
| 650 | 0 | 4 |
_aRadiodermatitis _xepidemiology |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 650 | 0 | 4 |
_aStomach _xradiation effects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAlonso Redondo, E | |
| 700 | 1 | _aLeón Jiménez, A | |
| 700 | 1 | _aRueda Ramos, A | |
| 773 | 0 |
_tArchivos de bronconeumologia _gvol. 39 _gno. 2 _gp. 81-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0300-2896(03)75327-7 _zAvailable from publisher's website |
| 999 |
_c12383433 _d12383433 |
||